Success Metrics

Clinical Success Rate
72.7%

Based on 8 completed trials

Completion Rate
73%(8/11)
Active Trials
0(0%)
Results Posted
100%(8 trials)
Terminated
3(25%)

Phase Distribution

Ph phase_3
5
42%
Ph phase_1
4
33%
Ph phase_2
2
17%

Phase Distribution

4

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
4(36.4%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
5(45.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

72.7%

8 of 11 finished

Non-Completion Rate

27.3%

3 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(8)
Terminated(3)

Detailed Status

Completed8
Terminated3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
72.7%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (36.4%)
Phase 22 (18.2%)
Phase 35 (45.5%)

Trials by Status

not_yet_recruiting18%
terminated325%
completed867%

Recent Activity

0 active trials
Showing 5 of 12
not_yet_recruiting

Delafloxacin Plasma and Tissue Concentration in Patients With Skin, Soft Tissue, and Bone and Joint Infections.

NCT07426471
terminatedphase_1

A Study Comparing the Bioavailability of a Taste-masked Delafloxacin Powder for Oral Suspension With the Delafloxacin Tablet in Healthy Adults

NCT06612255
terminatedphase_3

Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections

NCT04042077
completedphase_3

Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia

NCT02679573
completedphase_2

A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections

NCT01283581
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07426471

Delafloxacin Plasma and Tissue Concentration in Patients With Skin, Soft Tissue, and Bone and Joint Infections.

Not Yet Recruiting
NCT06612255Phase 1

A Study Comparing the Bioavailability of a Taste-masked Delafloxacin Powder for Oral Suspension With the Delafloxacin Tablet in Healthy Adults

Terminated
NCT04042077Phase 3

Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections

Terminated
NCT02679573Phase 3

Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia

Completed
NCT01283581Phase 2

A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections

Completed
NCT03534622Phase 1

Evaluate Safety and Pharmacokinetic To Assess Bronchopulmonary Disposition of Intravenous Delafloxacin in Healthy Adults

Completed
NCT02015637Phase 3

Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea

Terminated
NCT01984684Phase 3

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Completed
NCT01811732Phase 3

Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Completed
NCT02505997Phase 1

Study to Evaluate the Effect of Delafloxacin on the Pharmacokinetics of Midazolam in Healthy Subjects

Completed
NCT02245243Phase 1

Pharmacokinetics of Delafloxacin in Subjects With and Without Hepatic Impairment

Completed
NCT00719810Phase 2

Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12